Compare AXON & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | RMD |
|---|---|---|
| Founded | 1993 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 36.8B |
| IPO Year | 2001 | N/A |
| Metric | AXON | RMD |
|---|---|---|
| Price | $516.61 | $241.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $767.85 | $293.70 |
| AVG Volume (30 Days) | ★ 1.0M | 925.3K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $2,779,536,000.00 | N/A |
| Revenue This Year | $31.28 | $10.64 |
| Revenue Next Year | $28.23 | $7.38 |
| P/E Ratio | $350.63 | ★ $25.61 |
| Revenue Growth | ★ 33.47 | N/A |
| 52 Week Low | $396.41 | $199.92 |
| 52 Week High | $885.92 | $293.81 |
| Indicator | AXON | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 35.74 |
| Support Level | $508.72 | N/A |
| Resistance Level | $597.57 | $259.37 |
| Average True Range (ATR) | 26.38 | 5.44 |
| MACD | 6.63 | -1.60 |
| Stochastic Oscillator | 59.49 | 10.06 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, productivity and real-time operations software, body cameras, in-car cameras, TASER energy devices, drones and robotic security, and training solutions. The company's operation comprises of two operating segments, Software and Sensors, and TASER. The company generates the majority of its revenue from the Software and Sensors segment, which is engaged in developing, manufacturing, and selling fully integrated hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.